Log in

Teva Pharmaceutical Industries Price Target & Analyst Ratings (NYSE:TEVA)

+0.28 (+3.00 %)
(As of 11/13/2019 01:53 AM ET)
Today's Range
Now: $9.61
50-Day Range
MA: $7.63
52-Week Range
Now: $9.61
Volume19.81 million shs
Average Volume16.96 million shs
Market Capitalization$10.49 billion
P/E Ratio3.43
Dividend YieldN/A

Analyst Ratings

Teva Pharmaceutical Industries (NYSE:TEVA) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
24 Wall Street analysts have issued ratings and price targets for Teva Pharmaceutical Industries in the last 12 months. Their average twelve-month price target is $10.23, suggesting that the stock has a possible upside of 6.42%. The high price target for TEVA is $20.00 and the low price target for TEVA is $6.00. There are currently 4 sell ratings, 14 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score:
Ratings Breakdown: 4 Sell Rating(s)
14 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
5 Sell Rating(s)
13 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
4 Sell Rating(s)
14 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
16 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $10.23$10.59$12.74$20.33
Price Target Upside: 6.42% upside53.05% upside81.73% upside41.60% upside

Teva Pharmaceutical Industries (NYSE:TEVA) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Teva Pharmaceutical Industries (NYSE:TEVA) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/12/2019JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$8.00Medium
11/8/2019Piper Jaffray CompaniesBoost Price TargetNeutral$6.00 ➝ $7.00Low
10/16/2019GabelliUpgradeHold ➝ BuyHigh
9/30/2019Wells Fargo & CoLower Price TargetMarket Perform$17.00 ➝ $8.00Low
9/12/2019GuggenheimInitiated CoverageNeutralLow
8/16/2019UBS GroupSet Price TargetHold$8.00High
8/9/2019BMO Capital MarketsLower Price TargetMarket Perform$11.00 ➝ $9.00N/A
8/8/2019Royal Bank of CanadaReiterated RatingHold$10.00High
8/8/2019SunTrust BanksLower Price TargetHold$7.00Medium
8/8/2019Raymond JamesLower Price TargetOutperform$22.00 ➝ $15.00Medium
8/7/2019CowenSet Price TargetHold$9.00Low
7/19/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer Perform$9.00Low
7/15/2019Morgan StanleyDowngradeEqual Weight ➝ Underweight$16.00 ➝ $6.00High
7/10/2019Credit Suisse GroupReiterated RatingNeutralLow
7/5/2019ArgusUpgradeHold ➝ Buy$12.00High
6/18/2019Sanford C. BernsteinLower Price TargetMarket Perform$17.00 ➝ $11.00Medium
6/17/2019MizuhoSet Price TargetHold$11.00Medium
6/17/2019CitigroupSet Price TargetBuy$23.00 ➝ $13.00Low
6/12/2019OppenheimerSet Price TargetBuy$12.00High
6/12/2019Cantor FitzgeraldLower Price TargetNeutral$16.00 ➝ $9.00Low
6/11/2019BarclaysInitiated CoverageUnderweight ➝ Underweight$8.00Medium
6/3/2019CIBCUpgradeMarket Perform ➝ Outperform$12.00Medium
5/30/2019Bank of AmericaDowngradeBuy ➝ Underperform$19.00 ➝ $9.00High
5/2/2019Maxim GroupReiterated RatingHoldLow
2/5/2019HSBCSet Price TargetSell$12.00High
10/1/2018Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$30.00High
10/1/2018Leerink SwannUpgradeUnderperform ➝ Market Perform$16.00 ➝ $24.00High
9/17/2018BTIG ResearchUpgradeSell ➝ NeutralHigh
8/3/2018Jefferies Financial GroupReiterated RatingHold$21.00Medium
2/9/2018Deutsche BankLower Price TargetHold ➝ Hold$20.00 ➝ $18.00Medium
1/25/2018Susquehanna BancsharesReiterated RatingPositive ➝ Positive$22.00 ➝ $24.00Medium
(Data available from 11/13/2017 forward)
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Featured Article: Special Dividends

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel